Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma
MALVERN, Pa. & CHONGQING, China--(BUSINESS WIRE)--Resolian, a global bioanalytical contract research organization (CRO) specializing in…
2 years ago
Wire Stories
Genome Insight Secures $23 Million in Series B-2 Funding Round
SAN DIEGO--(BUSINESS WIRE)--Genome Insight, a precision healthcare solutions company promoting whole-genome technology for accurate diagnosis…
2 years ago
Silicon Mitus and Pico Semiconductor Partner to Develop Ultra-Small High-Frequency Silicon Capacitors
SEOUL, South Korea--(BUSINESS WIRE)--#Capacitor--Silicon Mitus (CEO Huh Youm), a company specializing in power management and…
2 years ago
Ceridian Reports Third Quarter 2023 Results
Dayforce® recurring revenue of $279.6 million, up 34.6% year-over-year, or 34.9% on a constant currency…
2 years ago
IperionX Receives US$12.7M U.S. Department of Defense Grant for Domestic Titanium Production
CHARLOTTE, N.C.--(BUSINESS WIRE)--$IPX #Virginia--IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to announce that…
2 years ago
Gilat Awarded Approximately $20 Million in Contract Renewal and Extension from Tier-1 MNO in the USA
Gilat continues to support this long-term Tier-1 customer with a multi-year end-to-end managed services contract…
2 years ago
Global Copper Tubes Industry Report 2023-2028: Breakdown and Analysis of Straight Length, Coils, Pancakes or Flattened Tubes, U-Bends & Drawn Tubes – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Copper Tubes Market by Type (Straight Length, Coils, Pancakes or Flattened Tubes,…
2 years ago
Radware Reports Third Quarter 2023 Financial Results
Third Quarter 2023 Financial Results and Highlights Revenue of $61.6 million, down 13% year-over-year Cloud…
2 years ago
Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes Using iPS Cells from I Peace, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine
TOKYO & PALO ALTO, Calif.--(BUSINESS WIRE)--#Heartseed--Heartseed Inc. ("Heartseed"), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes…
2 years ago
Janus Henderson Group plc Reports Third Quarter 2023 Results
Solid investment performance, with 65%, 58%, 67%, and 72% of assets under management (“AUMâ€) outperforming…
2 years ago